Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 234 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISEDRONATE 35MG TABLET Resolved 2018-08-21 2018-10-19 58626
APO-RISEDRONATE 35MG TABLET Resolved 2018-10-19 2018-12-21 64981
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-11-04 95874
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2020-10-07 2020-12-29 125809
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2020-12-11 2021-01-20 130040
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2021-03-26 2021-04-12 136409
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2021-06-11 2021-07-26 140777
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2021-12-03 2021-12-20 150432
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2022-11-04 2022-12-09 173823
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2024-02-09 2024-03-08 219141
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Actual shortage 2024-04-26 2024-04-26 226309
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-10 2017-04-01 384
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-08-31 16942
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-10 28553
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-06-04 37966
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-19 2019-07-17 70146
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-04 2020-08-17 116542
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-09 2021-05-01 137261
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-09 2021-05-01 137264
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-07 2021-07-02 138963

Showing 1921 to 1940 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-09-07 2018-09-15 60241
APO-CYCLOSPORINE ORAL SOLUTION Discontinued 2018-09-07 2018-09-15 60408
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-12-21 2018-12-24 70347
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029

Showing 1 to 20 of 356